|
|
Line 426: |
Line 426: |
| ! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Lab Findings | | ! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Lab Findings |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging | | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging |
| | |- |
| | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Primary sclerosing cholangitis]] |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[RUQ]] |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | |
| | * Increased liver enzymes |
| | * Increased [[IgM]], [[IgG]]4 |
| | * [[Anti-neutrophil cytoplasmic antibody]] ([[p-ANCA]]) |
| | * [[Anti-nuclear antibody]] ([[ANA]]) |
| | * [[Anti-smooth muscle antibody]] (Anti-Sm) |
| | * Anti-endothelial antibody |
| | * Anti-cardiolipin antibody |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |ERCP and MRCP shows |
| | * Multiple segmental [[strictures]] |
| | * Mural irregularities |
| | * [[Biliary]] dilatation and diverticula |
| | * Distortion of biliary tree |
| | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | |
| | * The risk of [[cholangiocarcinoma]] in patients with primary sclerosing cholangitis is 400 times higher than the risk in the general population. |
| |- | | |- |
| | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Acute suppurative cholangitis | | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Acute suppurative cholangitis |
Line 608: |
Line 638: |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | |
| * Pruritis | | * Pruritis |
| |-
| |
| | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Primary sclerosing cholangitis]]
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[RUQ]]
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" |−
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Increased liver enzymes
| |
| * Increased [[IgM]], [[IgG]]4
| |
| * [[Anti-neutrophil cytoplasmic antibody]] ([[p-ANCA]])
| |
| * [[Anti-nuclear antibody]] ([[ANA]])
| |
| * [[Anti-smooth muscle antibody]] (Anti-Sm)
| |
| * Anti-endothelial antibody
| |
| * Anti-cardiolipin antibody
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |ERCP and MRCP shows
| |
| * Multiple segmental [[strictures]]
| |
| * Mural irregularities
| |
| * [[Biliary]] dilatation and diverticula
| |
| * Distortion of biliary tree
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * The risk of [[cholangiocarcinoma]] in patients with primary sclerosing cholangitis is 400 times higher than the risk in the general population.
| |
| |- | | |- |
| | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cholelithiasis]] | | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cholelithiasis]] |
Line 970: |
Line 970: |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging | | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Comments | | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Comments |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hemochromatosis]]
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" |RUQ
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | Positive in cirrhotic patients
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="center" | −
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * >60% TS
| |
| * >240 μg/L SF
| |
| * Raised LFT <br>Hyperglycemia
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
| |
| * Ultrasound shows evidence of cirrhosis
| |
| | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Extra intestinal findings:
| |
| * Hyperpigmentation
| |
| * Diabetes mellitus
| |
| * Arthralgia
| |
| * Impotence in males
| |
| * Cardiomyopathy
| |
| * Atherosclerosis
| |
| * Hypopituitarism
| |
| * Hypothyroidism
| |
| * Extrahepatic cancer
| |
| * Prone to specific infections
| |
| |- | | |- |
| | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cirrhosis|Cirrhosis]] | | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cirrhosis|Cirrhosis]] |
Line 1,029: |
Line 997: |
| * Stigmata of liver disease | | * Stigmata of liver disease |
| * Cruveilhier- Baumgarten murmur | | * Cruveilhier- Baumgarten murmur |
| |-
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Disease
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Abdominal Pain
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Rigors and chills
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Nausea or vomiting
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Jaundice
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Constipation
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Diarrhea
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |GI bleeding
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Hypo-
| |
| tension
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Guarding
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Rebound Tenderness
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Bowel sounds
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging
| |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Comments
| |
| |- | | |- |
| | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Spontaneous bacterial peritonitis]] | | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Spontaneous bacterial peritonitis]] |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Overview
Primary sclerosing cholangitis must be differentiated from causes of secondary sclerosing cholangitis.
Differentiating Primary sclerosing cholangitis from other Diseases
Primary sclerosing cholangitis must be differentiated from causes of secondary sclerosing cholangitis. These include:[1][2]
Primary sclerosing cholangitis must be differentiated from other causes of jaundice:
Classification of jaundice based on etiology
|
Disease
|
History and clinical manifestations
|
Diagnosis
|
Lab Findings
|
Other blood tests
|
Other diagnostic
|
Family history
|
Fever
|
RUQ Pain
|
Pruritis
|
AST
|
ALT
|
ALK
|
BLR Indirect
|
BLR Direct
|
Viral serology
|
Jaundice
|
Hepatocellular Jaundice
|
Hemochromatosis
|
+
|
-
|
-/+
|
-
|
↑
|
↑
|
↑/N
|
↑/N
|
N
|
-
|
Ferritin ↑
|
Liver biopsy
|
Wilson's disease
|
+
|
-
|
-/+
|
-
|
↑
|
↑
|
N
|
↑/N
|
N
|
-
|
Serum cerulloplasmin ↑
|
Liver biopsy
|
Viral hepatitis
|
-
|
-/+
|
-
|
-
|
↑
|
↑
|
N
|
↑/N
|
N
|
+
|
Specific viral antibody for each type
|
-
|
Alcoholic hepatitis
|
-
|
-/+
|
-/+
|
-
|
↑↑
|
↑
|
N
|
↑/N
|
N
|
-
|
-
|
-
|
Drug induced hepatitis
|
-
|
-/+
|
-
|
-
|
↑
|
↑
|
N
|
↑/N
|
N
|
-
|
-
|
-
|
Autoimmune hepatitis
|
-/+
|
-
|
-
|
-/+
|
↑
|
↑
|
N
|
↑/N
|
N
|
-
|
Anti-LKM antibody
|
Liver biopsy
|
Cirrhosis
|
-/+
|
-/+
|
-/+
|
-
|
↑
|
↑
|
↑/N
|
↑/N
|
↑/N
|
-/+
|
Low platate
|
Small liver on ultrasond
|
Cholestatic Jaundice
|
Common bile duct stone
|
-/+
|
-
|
+
|
+
|
N
|
N
|
↑
|
N
|
↑
|
-
|
Dilated ducts on sono
|
CT/ERCP
|
Hepatitis A cholestatic type
|
-
|
-/+
|
+
|
+
|
N
|
N
|
↑
|
N
|
↑
|
+
|
HAV- AB
|
Abdominal ultrasound
|
EBV / CMV hepatitis
|
-
|
-/+
|
+
|
+
|
N
|
N
|
↑
|
N
|
↑
|
+
|
Positive serology
|
|
Primary biliary cirrhosis
|
-/+
|
-
|
-/+
|
+
|
N/↑
|
N/↑
|
↑
|
N
|
↑
|
-
|
AMA positive
|
Liver biopsy
|
Primary sclerosing cholangitis
|
-/+
|
-
|
-/+
|
+
|
N/↑
|
N/↑
|
↑
|
N
|
↑
|
-
|
Beading on MRCP
|
Liver biopsy
|
Pancreatic carcinoma
|
+
|
-
|
-/+
|
-
|
N/↑
|
N/↑
|
↑
|
N
|
↑
|
-
|
Mass on ultrasond
|
CT scan for diagnosis
|
Isolated Jaundice
|
Crigler-Najjar type 2
|
+
|
-
|
-
|
-
|
N
|
N
|
N
|
↑
|
↑
|
-
|
Genetic testing
|
Gilbert
|
+
|
-
|
-
|
-
|
N
|
N
|
N
|
↑
|
↑
|
-
|
Genetic testing
|
Rotor syndrome
|
+
|
-
|
-
|
-
|
N
|
N
|
N
|
N
|
↑
|
-
|
Genetic testing
|
Liver biopsy
|
Dubin-Johnson syndrome
|
+
|
-
|
-
|
-
|
N
|
N
|
N
|
N
|
↑
|
-
|
Genetic testing
|
Liver biopsy
|
Hereditory spherocytosis
|
+
|
-
|
-/+
|
-
|
N
|
N
|
N
|
↑
|
N
|
-
|
Genetic testing
|
Osmotic fragility
|
G6PD deficiency
|
+
|
-
|
-
|
-
|
N
|
N
|
N
|
↑
|
N
|
-
|
Genetic testing
|
Thalassemia
|
+
|
-
|
-
|
-
|
N
|
N
|
N
|
↑
|
N
|
-
|
Genetic testing
|
Sickle cell disease
|
+
|
-
|
-
|
-
|
N
|
N
|
N
|
↑
|
N
|
-
|
Genetic testing
|
Paroxismal nocturnal hemoglobinoria
|
-
|
-
|
-
|
-
|
N
|
N
|
N
|
↑
|
N
|
-
|
Flocytometery
|
Immune hemolysis
|
-
|
-/+
|
-
|
-
|
N
|
N
|
N
|
↑
|
N
|
-
|
Autoantibodies
|
Hematoma
|
-
|
-/+
|
-
|
-
|
N
|
N
|
N
|
↑
|
N
|
-
|
Anemia
|
Truma or surgery in history
|
|
Abbreviations:
RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin, SMA= Superior mesenteric artery, SMV= Superior mesenteric vein, ECG= Electrocardiogram
Primary sclerosing cholangitis must be differentiated from other abdominal pain causes:
Disease
|
Clinical manifestations
|
Diagnosis
|
Comments
|
Symptoms
|
Signs
|
Abdominal Pain
|
Fever
|
Rigors and chills
|
Nausea or vomiting
|
Jaundice
|
Constipation
|
Diarrhea
|
Weight loss
|
GI bleeding
|
Hypo-
tension
|
Guarding
|
Rebound Tenderness
|
Bowel sounds
|
Lab Findings
|
Imaging
|
Primary sclerosing cholangitis
|
RUQ
|
+
|
−
|
−
|
+
|
−
|
−
|
−
|
−
|
−
|
−
|
−
|
N
|
|
ERCP and MRCP shows
- Multiple segmental strictures
- Mural irregularities
- Biliary dilatation and diverticula
- Distortion of biliary tree
|
- The risk of cholangiocarcinoma in patients with primary sclerosing cholangitis is 400 times higher than the risk in the general population.
|
Acute suppurative cholangitis
|
RUQ
|
+
|
+
|
+
|
+
|
−
|
−
|
−
|
−
|
+
|
+
|
+
|
N
|
|
- Ultrasound shows biliary dilatation/stents/tumor
|
- Septic shock occurs with features of SIRS
|
Acute cholangitis
|
RUQ
|
+
|
−
|
−
|
+
|
−
|
−
|
−
|
−
|
−
|
−
|
−
|
N
|
|
- Ultrasound shows biliary dilatation/stents/tumor
|
- Biliary drainage (ERCP) + IV antibiotics
|
Acute cholecystitis
|
RUQ
|
+
|
−
|
+
|
+
|
−
|
−
|
−
|
−
|
−
|
−
|
−
|
Hypoactive
|
|
Ultrasound shows:
|
|
Acute pancreatitis
|
Epigastric
|
+
|
−
|
+
|
±
|
−
|
−
|
−
|
−
|
±
|
−
|
−
|
N
|
|
- Ultrasound shows evidence of inflammation
- CT scan shows severity of pancreatitis
|
|
Chronic pancreatitis
|
Epigastric
|
−
|
−
|
±
|
±
|
−
|
+
|
+
|
−
|
−
|
−
|
−
|
N
|
- Increased amylase / lipase
- Increased stool fat content
- Pancreatic function test
|
CT scan
- Calcification
- Pseudocyst
- Dilation of main pancreatic duct
|
- Predisposes to pancreatic cancer
|
Pancreatic carcinoma
|
Epigastric
|
−
|
−
|
+
|
+
|
−
|
+
|
+
|
−
|
−
|
−
|
−
|
N
|
|
|
Skin manifestations may include:
|
Disease
|
Abdominal Pain
|
Fever
|
Rigors and chills
|
Nausea or vomiting
|
Jaundice
|
Constipation
|
Diarrhea
|
Weight loss
|
GI bleeding
|
Hypo-
tension
|
Guarding
|
Rebound Tenderness
|
Bowel sounds
|
Lab Findings
|
Imaging
|
Comments
|
Primary biliary cirrhosis
|
RUQ/Epigastric
|
−
|
−
|
−
|
+
|
−
|
−
|
−
|
−
|
−
|
−
|
−
|
N
|
- Increased AMA level, abnormal LFTs
|
|
|
Cholelithiasis
|
RUQ/Epigastric
|
±
|
−
|
±
|
±
|
−
|
−
|
−
|
−
|
−
|
−
|
−
|
Normal to hyperactive for dislodged stone
|
|
|
|
Peptic ulcer disease
|
Diffuse
|
±
|
−
|
+
|
−
|
−
|
−
|
+
|
|
Positive if perforated
|
Positive if perforated
|
Positive if perforated
|
N
|
- Ascitic fluid
- LDH > serum LDH
- Glucose < 50mg/dl
- Total protein > 1g/dl
|
|
|
Disease
|
Abdominal Pain
|
Fever
|
Rigors and chills
|
Nausea or vomiting
|
Jaundice
|
Constipation
|
Diarrhea
|
Weight loss
|
GI bleeding
|
Hypo-
tension
|
Guarding
|
Rebound Tenderness
|
Bowel sounds
|
Lab Findings
|
Imaging
|
Comments
|
Acute appendicitis
|
Starts in epigastrium, migrates to RLQ
|
+
|
Positive in pyogenic appendicitis
|
+
|
−
|
−
|
±
|
−
|
−
|
Positive in perforated appendicitis
|
+
|
+
|
Hypoactive
|
|
|
- Positive Rovsing sign
- Positive Obturator sign
- Positive Iliopsoas sign
|
Acute diverticulitis
|
LLQ
|
+
|
±
|
+
|
−
|
+
|
±
|
−
|
+
|
Positive in perforated diverticulitis
|
+
|
+
|
Hypoactive
|
|
|
|
Inflammatory bowel disease
|
Diffuse
|
±
|
−
|
−
|
±
|
−
|
+
|
+
|
+
|
−
|
−
|
−
|
Normal or hyperactive
|
|
|
Extra intestinal findings:
|
Irritable bowel syndrome
|
Diffuse
|
−
|
−
|
−
|
−
|
±
|
±
|
+
|
−
|
−
|
−
|
−
|
N
|
Normal
|
Normal
|
Symptomatic treatment
|
Whipple's disease
|
Diffuse
|
±
|
−
|
−
|
±
|
−
|
+
|
+
|
−
|
±
|
−
|
−
|
N
|
|
Endoscopy is used to confirm diagnosis.
Images used to find complications
|
Extra intestinal findings:
|
Disease
|
Abdominal Pain
|
Fever
|
Rigors and chills
|
Nausea or vomiting
|
Jaundice
|
Constipation
|
Diarrhea
|
Weight loss
|
GI bleeding
|
Hypo-
tension
|
Guarding
|
Rebound Tenderness
|
Bowel sounds
|
Lab Findings
|
Imaging
|
Comments
|
Colon carcinoma
|
Diffuse/localized
|
−
|
−
|
−
|
−
|
±
|
±
|
+
|
+
|
±
|
−
|
−
|
- Normal or hyperactive if obstruction present
|
- CBC
- Carcinoembryonic antigen (CEA)
|
- Colonoscopy
- Flexible sigmoidoscopy
- Barium enema
- CT colonography
|
- PILLCAM 2: A colon capsule for CRC screening may be used in patients with an incomplete colonoscopy who lacks obstruction
|
Viral hepatitis
|
RUQ
|
+
|
−
|
+
|
+
|
−
|
Positive in Hep A and E
|
+
|
−
|
Positive in fulminant hepatitis
|
Positive in acute
|
+
|
N
|
- Abnormal LFTs
- Viral serology
|
|
- Hep A and E have fecal-oral route of transmission
- Hep B and C transmits via blood transfusion and sexual contact.
|
Liver abscess
|
RUQ
|
+
|
+
|
+
|
+
|
−
|
±
|
+
|
−
|
+
|
+
|
±
|
Normal or hypoactive
|
|
|
|
Hepatocellular carcinoma/Metastasis
|
RUQ
|
+
|
−
|
−
|
+
|
−
|
−
|
+
|
−
|
−
|
−
|
−
|
- Normal
- Hyperactive if obstruction present
|
|
|
Other symptoms:
|
Disease
|
Abdominal Pain
|
Fever
|
Rigors and chills
|
Nausea or vomiting
|
Jaundice
|
Constipation
|
Diarrhea
|
Weight loss
|
GI bleeding
|
Hypo-
tension
|
Guarding
|
Rebound Tenderness
|
Bowel sounds
|
Lab Findings
|
Imaging
|
Comments
|
Cirrhosis
|
RUQ
|
−
|
−
|
−
|
+
|
−
|
−
|
+
|
+
|
+
|
−
|
−
|
N
|
|
US
|
- Stigmata of liver disease
- Cruveilhier- Baumgarten murmur
|
Spontaneous bacterial peritonitis
|
Diffuse
|
+
|
−
|
−
|
Positive in cirrhotic patients
|
−
|
+
|
−
|
−
|
±
|
+
|
+
|
Hypoactive
|
- Ascitic fluid PMN>250 cells/mm³
- Culture: Positive for single organism
|
- Ultrasound for evaluation of liver cirrhosis
|
|
Biliary colic
|
RUQ
|
−
|
−
|
+
|
+
|
−
|
−
|
−
|
−
|
−
|
−
|
−
|
N
|
|
|
|
|
References
- ↑ Lazaridis KN, LaRusso NF (2016). "Primary Sclerosing Cholangitis". N. Engl. J. Med. 375 (12): 1161–70. doi:10.1056/NEJMra1506330. PMID 27653566.
- ↑ Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ (2010). "Diagnosis and management of primary sclerosing cholangitis". Hepatology. 51 (2): 660–78. doi:10.1002/hep.23294. PMID 20101749.
Template:WikiDoc Sources